To assess the association of the FAT1 signature with clinical and pathological features in HNSCC, we compared the FAT1‐LR and FAT1‐HR subgroups in the five HNSCC cohorts (n = 1079). Here, FAT1 is linked to head and neck squamous cell carcinoma.